Journal for ImmunoTherapy of Cancer : Impact Factor & More
eISSN: 2051-1426pISSN: 2051-1426
Open AccessShare this on:
Key Metrics
CiteScore 
14.3
Eigenfactor
0.01 - 0.05
Impact Factor
10 - 15
Scite Index
0.90 5-Year SI
SJR
Q1Oncology
SNIP
2.23
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | BMJ PUBLISHING GROUP |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2885 |
| Publication Time | 18 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | Society for Immunotherapy of Cancer |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC, CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Journal for ImmunoTherapy of Cancer ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Journal for ImmunoTherapy of Cancer
Clinical trial landscape and translational prospects of natural killer cell-based immunotherapy: an analysis based on the INFORMA database.
- 7 Aug 2026
- Journal for immunotherapy of cancer
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
- 7 Aug 2026
- Journal for immunotherapy of cancer
Streptococcus anginosus-associated kynurenic acid drives PD-1 blockade resistance through an ITGA2-mTOR-CTSV axis in gastric cancer
- 6 Aug 2026
- Journal for Immunotherapy of Cancer
TGF-\u03b21 drives neutrophil extracellular traps formation to promote CD8+ T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
\u03b2-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
\u201cYong\u201d syndrome\u2013cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
Clinical trial landscape and translational prospects of natural killer cell-based immunotherapy: an analysis based on the INFORMA database.
- 7 Aug 2026
- Journal for immunotherapy of cancer
Circulating B cell and T cell activation states predict clinical outcomes in melanoma and reveal dynamic immune reinvigoration with checkpoint inhibitor immunotherapy.
- 7 Aug 2026
- Journal for immunotherapy of cancer
Streptococcus anginosus-associated kynurenic acid drives PD-1 blockade resistance through an ITGA2-mTOR-CTSV axis in gastric cancer
- 6 Aug 2026
- Journal for Immunotherapy of Cancer
TGF-\u03b21 drives neutrophil extracellular traps formation to promote CD8+ T cell exhaustion via the ERK-c-Fos-JunB axis, mediating gastric cancer immunotherapy resistance
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
\u03b2-glucan elicits APOE-dependent peripheral trained immunity to suppress hepatocellular carcinoma
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
\u201cYong\u201d syndrome\u2013cGAS-STING axis: a TCM syndrome-based hypothesis for overcoming primary anti-PD-1 resistance in gastric cancer
- 4 Aug 2026
- Journal for Immunotherapy of Cancer
FAQs on Journal for ImmunoTherapy of Cancer
How long has Journal for ImmunoTherapy of Cancer been actively publishing? 
What is the publishing frequency of Journal for ImmunoTherapy of Cancer?
How many articles did Journal for ImmunoTherapy of Cancer publish last year?
What is the eISSN & pISSN for Journal for ImmunoTherapy of Cancer?
What is Citescore for Journal for ImmunoTherapy of Cancer?
What is SNIP score for Journal for ImmunoTherapy of Cancer?
What is the SJR for Journal for ImmunoTherapy of Cancer?
Who is the publisher of Journal for ImmunoTherapy of Cancer?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2022 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations